Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.74 -0.02 (0.05%)
Previous Close $36.76    52 Week High $66.55 
Open $36.82    52 Week Low $37.82 
Day High $37.32    P/E N/A 
Day Low $36.70    EPS $0.00 
Volume 1,209,553       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.74 -0.02 (0.05%)
Previous Close $36.76    52 Week High $66.55 
Open $36.82    52 Week Low $37.82 
Day High $37.32    P/E N/A 
Day Low $36.70    EPS $0.00 
Volume 1,209,553